ProAxsis CEO to present at Biotech and Money conference

Date : January 28, 2016

Dr David Ribeiro

Dr David Ribeiro, CEO of ProAxsis, will be attending the Biotech and Money - London 2016 conference, taking place in London on February 2nd-3rd 2016, and will be presenting in the Ones to Watch session between 11.00h and 13.00h on February 3rd.  The conference is designed to help build linkages and business opportunities for UK life science companies, capital and partners, and is expected to accommodate more than 350 delegates.

Dr Ribeiro said: “As a company in its early infancy, it is important that we continue to publicize the excellent capabilities we have in the capture, detection and measurement of active protease biomarkers of disease to as wide an audience as possible. Conferences such as Biotech and Money offer an excellent opportunity to maximise the awareness of ProAxsis amongst the investor and life science communities, and we’ll be seeking further similar opportunities throughout 2016.”

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies.  The company is also supported by QUBIS, the commercialisation arm of Queens University .